摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

N-(3-chloro-4-(4-methyl-1,3-dioxoisoindolin-2-yl)phenyl)-2-picolinamide | 1218926-22-7

中文名称
——
中文别名
——
英文名称
N-(3-chloro-4-(4-methyl-1,3-dioxoisoindolin-2-yl)phenyl)-2-picolinamide
英文别名
N-[3-chloro-4-(4-methyl-1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)phenyl]pyridine-2-carboxamide;N-[3-chloro-4-(4-methyl-1,3-dioxoisoindol-2-yl)phenyl]pyridine-2-carboxamide
N-(3-chloro-4-(4-methyl-1,3-dioxoisoindolin-2-yl)phenyl)-2-picolinamide化学式
CAS
1218926-22-7
化学式
C21H14ClN3O3
mdl
——
分子量
391.813
InChiKey
ANBBLLOZDHXSOE-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.5
  • 重原子数:
    28
  • 可旋转键数:
    3
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.05
  • 拓扑面积:
    79.4
  • 氢给体数:
    1
  • 氢受体数:
    4

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    N-(3-chloro-4-(4-methyl-1,3-dioxoisoindolin-2-yl)phenyl)-2-picolinamideN-碘代丁二酰亚胺三氟甲磺酸 作用下, 生成 N-[5-chloro-2-iodo-4-(5-iodo-4-methyl-1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)phenyl]pyridine-2-carboxamide
    参考文献:
    名称:
    [EN] PHTHALIMIDE DERIVATIVE METABOTROPIC GLUTAMATE R4 LIGANDS
    [FR] LIGANDS DU GLUTAMATE MÉTABOTROPIQUE R4 DÉRIVÉ DE PHTALAMIDE
    摘要:
    本文披露了一般式(I)的mGluR4阳性变构调节剂配体以及放射标记衍生物,它们被用作治疗中枢神经系统疾病的治疗剂,这些疾病受mGluR4调节,并且作为哺乳动物中mGluR4的标记和诊断成像的配体。
    公开号:
    WO2010033349A1
  • 作为产物:
    描述:
    2-吡啶甲酰氯 在 palladium 10% on activated carbon 、 氢气溶剂黄146三乙胺 作用下, 以 四氢呋喃甲醇乙酸乙酯 为溶剂, 20.0~100.0 ℃ 、303.99 kPa 条件下, 反应 25.0h, 生成 N-(3-chloro-4-(4-methyl-1,3-dioxoisoindolin-2-yl)phenyl)-2-picolinamide
    参考文献:
    名称:
    Radiosynthesis and Evaluation of an 18F-Labeled Positron Emission Tomography (PET) Radioligand for Metabotropic Glutamate Receptor Subtype 4 (mGlu4)
    摘要:
    Four 4-phthalimide derivatives of N-(3-chlorophenyl)-2-picolinamide were synthesized as potential ligands for the PET imaging of mGlu4 in the brain. Of these compounds, N-(3-chloro-4-(4-fluoro-1,3-dioxoisoindolin-2-yl)phenyl)-2-picolinamide (3, KALB001) exhibited improved binding affinity (IC50 = 5.1 nM) compared with ML128 (1) and was subsequently labeled with F-18. When finally formulated in 0.1 M citrate buffer (pH 4) with 10% ethanol, the specific activity of [F-18]3 at the end of synthesis (EOS) was 233.5 +/- 177.8 GBq/mu mol (n = 4). The radiochemical yield of [F-18]3 was 16.4 +/- 4.8% (n = 4), and the purity was over 98%. In vivo imaging studies in a monkey showed that the radiotracer quickly penetrated the brain with the highest accumulation in the brain areas known to express mGlu4. Despite some unfavorable radiotracer properties like fast washout in rodent studies, [F-18]3 is the first F-18-labeled mGlu4 radioligand, which can be further modified to improve pharmacokinetics and brain penetrability for future human studies.
    DOI:
    10.1021/jm501245b
点击查看最新优质反应信息

文献信息

  • PHTHALIMIDE DERIVATIVE METABOTROPIC GLUTAMATE R4 LIGANDS
    申请人:McCauley John A.
    公开号:US20110318266A1
    公开(公告)日:2011-12-29
    Disclosed are mGluR4 positive allosteric modulator ligands of general formula (I) and radiolabeled derivates, their use as therapeutic agents for the treatment of central nervous system disorders modulated by mGluR4 and as ligands for the labeling and diagnostic imaging of mGluR4 in mammals.
    本发明揭示了通式(I)的mGluR4阳性变构调节剂配体和放射性标记衍生物,它们可作为治疗中枢神经系统疾病的治疗剂,这些疾病受mGluR4调节,同时也可作为哺乳动物体内mGluR4的标记和诊断成像的配体。
  • MODULATORS OF METABOTROPIC GLUTAMATE RECEPTOR 4
    申请人:The General Hospital Corporation
    公开号:US20220118117A1
    公开(公告)日:2022-04-21
    The present application provides picolinamide compounds that can be used as allosteric positron emission tomography (“PET”) imaging probes. Methods of using these compounds for treating a neurodegenerative disease are also provided.
  • Radiosynthesis and Evaluation of an <sup>18</sup>F-Labeled Positron Emission Tomography (PET) Radioligand for Metabotropic Glutamate Receptor Subtype 4 (mGlu<sub>4</sub>)
    作者:Kun-Eek Kil、Pekka Poutiainen、Zhaoda Zhang、Aijun Zhu、Ji-Kyung Choi、Kimmo Jokivarsi、Anna-Liisa Brownell
    DOI:10.1021/jm501245b
    日期:2014.11.13
    Four 4-phthalimide derivatives of N-(3-chlorophenyl)-2-picolinamide were synthesized as potential ligands for the PET imaging of mGlu4 in the brain. Of these compounds, N-(3-chloro-4-(4-fluoro-1,3-dioxoisoindolin-2-yl)phenyl)-2-picolinamide (3, KALB001) exhibited improved binding affinity (IC50 = 5.1 nM) compared with ML128 (1) and was subsequently labeled with F-18. When finally formulated in 0.1 M citrate buffer (pH 4) with 10% ethanol, the specific activity of [F-18]3 at the end of synthesis (EOS) was 233.5 +/- 177.8 GBq/mu mol (n = 4). The radiochemical yield of [F-18]3 was 16.4 +/- 4.8% (n = 4), and the purity was over 98%. In vivo imaging studies in a monkey showed that the radiotracer quickly penetrated the brain with the highest accumulation in the brain areas known to express mGlu4. Despite some unfavorable radiotracer properties like fast washout in rodent studies, [F-18]3 is the first F-18-labeled mGlu4 radioligand, which can be further modified to improve pharmacokinetics and brain penetrability for future human studies.
  • [EN] PHTHALIMIDE DERIVATIVE METABOTROPIC GLUTAMATE R4 LIGANDS<br/>[FR] LIGANDS DU GLUTAMATE MÉTABOTROPIQUE R4 DÉRIVÉ DE PHTALAMIDE
    申请人:MERCK & CO INC
    公开号:WO2010033349A1
    公开(公告)日:2010-03-25
    Disclosed are mGluR4 positive allosteric modulator ligands of general formula (I) and radiolabeled derivates, their use as therapeutic agents for the treatment of central nervous system disorders modulated by mGluR4 and as ligands for the labeling and diagnostic imaging of mGluR4 in mammals.
    本文披露了一般式(I)的mGluR4阳性变构调节剂配体以及放射标记衍生物,它们被用作治疗中枢神经系统疾病的治疗剂,这些疾病受mGluR4调节,并且作为哺乳动物中mGluR4的标记和诊断成像的配体。
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫 龙胆紫 齐达帕胺 齐诺康唑 齐洛呋胺 齐墩果-12-烯[2,3-c][1,2,5]恶二唑-28-酸苯甲酯 齐培丙醇 齐咪苯 齐仑太尔 黑染料 黄酮,5-氨基-6-羟基-(5CI) 黄酮,6-氨基-3-羟基-(6CI) 黄蜡,合成物 黄草灵钾盐